Ma Ning, Gao Fang
Department of Orthopedic Trauma, Norinco General Hospital, Xi'an, Shaanxi Province, China.
BMC Musculoskelet Disord. 2025 Jan 7;26(1):23. doi: 10.1186/s12891-024-08272-6.
Osteoarthritis (OA) is a common degenerative joint disease that significantly impacts the quality of life, especially among older adults. Testosterone, a critical hormone for musculoskeletal health, has been suggested to influence OA pathogenesis. However, the relationship between low testosterone levels and OA risk remains underexplored in large, representative populations. This study aimed to investigate the association between low testosterone levels and OA risk using data from the National Health and Nutrition Examination Survey (NHANES, 2011-2016).
This cross-sectional analysis included 4,548 participants from NHANES, a nationally representative U.S.
Testosterone levels were categorized as low or normal, with low testosterone defined as < 300 ng/dL for men and population-based cutoffs for women. The presence of OA was determined through self-reported physician diagnosis. Multivariable logistic regression models were used to examine the association between testosterone levels and OA risk, adjusting for demographic, socioeconomic, lifestyle, and clinical factors. Restricted cubic spline (RCS) analysis was conducted to evaluate non-linear relationships. Subgroup analyses were performed to assess consistency across key demographic and clinical strata.
Among the 4,548 participants, 812 (17.9%) were diagnosed with OA. Participants with OA were older, more likely to be female, and exhibited higher rates of obesity and hyperlipidemia. In fully adjusted models, low testosterone levels were significantly associated with increased OA risk (OR, 1.22; 95% CI, 1.02-1.46; P = 0.028). RCS analysis indicated a non-linear relationship, with a steep increase in OA risk at lower testosterone levels, suggesting a threshold effect. Subgroup analyses demonstrated consistent associations across demographic and clinical groups without significant interactions.
Low testosterone levels are independently associated with an increased risk of OA in the U.S.
These findings underscore the potential role of hormonal health in OA pathogenesis and highlight the need for longitudinal studies to clarify causal pathways. The observed non-linear relationship suggests that maintaining optimal testosterone levels may be important for joint health, and testosterone replacement therapy could be explored as a preventative strategy for individuals with testosterone deficiency.
骨关节炎(OA)是一种常见的退行性关节疾病,严重影响生活质量,在老年人中尤为如此。睾酮是对肌肉骨骼健康至关重要的一种激素,已被认为会影响骨关节炎的发病机制。然而,在大型代表性人群中,低睾酮水平与骨关节炎风险之间的关系仍未得到充分研究。本研究旨在利用美国国家健康与营养检查调查(NHANES,2011 - 2016年)的数据,调查低睾酮水平与骨关节炎风险之间的关联。
这项横断面分析纳入了来自NHANES的4548名参与者,这是一个具有全国代表性的美国数据集。睾酮水平分为低水平或正常水平,男性低睾酮定义为<300 ng/dL,女性则采用基于人群的临界值。骨关节炎的存在通过自我报告的医生诊断来确定。使用多变量逻辑回归模型来检验睾酮水平与骨关节炎风险之间的关联,并对人口统计学、社会经济、生活方式和临床因素进行调整。进行受限立方样条(RCS)分析以评估非线性关系。进行亚组分析以评估关键人口统计学和临床分层之间的一致性。
在4548名参与者中,812人(17.9%)被诊断患有骨关节炎。患有骨关节炎的参与者年龄更大,更可能为女性,且肥胖和高脂血症发生率更高。在完全调整模型中,低睾酮水平与骨关节炎风险增加显著相关(OR,1.22;95% CI,1.02 - 1.46;P = 0.028)。RCS分析表明存在非线性关系,在较低睾酮水平时骨关节炎风险急剧增加,提示存在阈值效应。亚组分析表明,各人口统计学和临床组之间的关联一致,无显著交互作用。
在美国人群中,低睾酮水平与骨关节炎风险增加独立相关。这些发现强调了激素健康在骨关节炎发病机制中的潜在作用,并突出了进行纵向研究以阐明因果途径的必要性。观察到的非线性关系表明,维持最佳睾酮水平可能对关节健康很重要,可以探索将睾酮替代疗法作为睾酮缺乏个体的预防策略。